grand case study v7 final 030310

Upload: jemimah-ruth-madayag

Post on 08-Apr-2018

222 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    1/49

    OBJECTIVES

    I. General Objective

    This study aims to present the case of a patient diagnosed with Kawasaki

    Disease and highlight the nursing management associated with the medical care

    provided to a patient with such a disease.

    II. Specific Objectives

    The following serve as a guide the accomplishment of the main objective:

    1. Since Kawasaki Disease is a rare yet potentially debilitating disease mostly

    seen in children, one of the goals of this study is to expand the knowledge

    and appreciation of the disease by presenting its clinical manifestations,

    complications, treatment, and prognoses;

    2. Kawasaki Disease is a systemic vasculitic disease with possible affectations

    of the heart, coronary arteries, skin, and lymph vessels, hence, this study

    aims to promote the nursing interventions needed for the symptomatictreatment of the disease;

    3. The incidence and treatment of Kawasaki Disease in the Philippines is not

    well documented, therefore, another goal of this study is to potentially serve

    as a significant reference for other researchers who wish to expand local

    knowledge about the disease.

    INTRODUCTION

    1

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    2/49

    I. Definition and History

    Kawasaki Disease (KD) is an acute febrile vasculitic syndrome that affects

    infants and young children. It is also known as Mucocutaneous Lymph Node

    Syndrome (MLNS). KD is now the leading cause of acquired heart disease in

    children in most developed countries. More than eighty-five percent (85%) of

    cases are children below five years of age and the mortality rate is presently 0.1

    to 2%. Mortality is based on complications, which include coronary arteritis,

    coronary artery aneurysms and stenoses, and coronary thrombosis which may

    lead to myocardial infarction, sudden death, or congestive heart failure. About

    twenty-five percent (25%) of untreated KD patients develop coronary artery

    aneurysms.

    KD was first observed and diagnosed in 1961 by Dr. Tomisaku Kawasaki

    at the Japan Red Cross Medical Center in Tokyo. Between 1961 to 1967, Dr.

    Kawasaki reported fifty (50) infants and young children who presented with

    several signs that included prolonged remittent fever, unilateral cervical

    lymphadenitis, bilateral conjunctival injection, polymorphous erythematous rash,

    erythema and edema of the hands and feet, inflammation of the lips and oralcavity, and subsequent desquamation of the fingers, toes, and periungual area.

    He ruled out other possible diagnoses after negative laboratory results and was

    convinced that he was treating a unique clinical syndrome. The first recorded

    case that had cardiac involvement was in 1968, when Kawasaki and a colleague

    reported a client manifesting with tachycardia, abnormal heart rhythm, and

    cardiomegaly. Several years after, Kawasaki presented post-mortem evidence

    of a number of patients diagnosed with KD who died due to coronary artery

    complications.

    KD is known to cause outbreaks in Japan, where the incidence of the

    disease is about 150 to 175 cases per 100,000 children or more than 10,000 new

    cases per year. In the United States, the incidence is about 15 per 100,000

    children or less than 4,000 new cases per year.

    2

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    3/49

    II. Possible Risk Factors

    The main cause or root of Kawasaki Disease is unknown. However,

    possible risk factors and causes have been researched and studied to identify

    the cause of the disease

    1. Age

    More than 90% of KD cases occur in children less than ten years of age.

    Eighty-five percent (85%) of cases were diagnosed in patients less than five

    years old and 50% in children younger than two years of age.

    2. Gender

    The ratio of male to female patients with KD is 1.5:1 internationally. It is

    evidently more common in males than in females.

    3. Race

    Worldwide, Japan has the highest rate of incidence with approximately

    10,000 new cases yearly. KD has been known to cause outbreaks in Japan

    usually during the winter and spring seasons. In the United States, the

    incidence is roughly 4,000 new cases yearly with rates intermediate among

    African-Americans and those with Asian and South Pacific ancestry other

    than Japan. In the Philippines, concrete data about the annual rate of KD isnot present.

    The cause of KD is idiopathic although some studies suggest it to be

    infectious. The bases for this assumption are the outbreaks reported in Japan

    and the United States during the winter and spring seasons where the incidence

    of KD doubles compared to the summer and fall seasons. Another reason for

    this assumption is the fact that the acute stage of KD is self-limiting even without

    IVIG medication.

    The following possible pathologic agents have been suggested:

    1. Parvovirus and Rotavirus infection

    2. HIV

    3

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    4/49

    3. Rubella

    4. Meningococcal septicemia

    5. Klebsiella pneumoniae bacteremia

    6. Coxiella burnettie

    7. Human lymphotropic virus infection

    III. Clinical Manifestations

    Kawasaki Disease has diagnostic criteria to distinguish it from other

    diseases with similar clinical manifestations.

    1. Fever for at least 5 days with at least four (4) of the following features:

    2. Bilateral conjuctival injection

    3. Polymorphous exanthema or rashes

    4. Changes in the lips and oral cavity (i.e. erythema, cracked lips, strawberry

    tongue)

    5. Changes in the peripheral extremities (i.e. edema in the hands and feet,

    desquamation of fingers, toes, and periungual area)

    6. Unilateral cervical lymphodenopathy (palpable; at least 1.5cm in diameter)

    7. Exclusion of other diseases with similar presentations

    The following signs and symptoms are present in the disease during its

    stages:

    Acute Stage (Days 1 to 11)

    High fever

    Irritability

    Bilateral conjunctivitis

    Rashes

    Strawberry tongue and lip fissures (cracks)

    Unilateral lymphadenitis

    Mild hepatic dysfunction

    4

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    5/49

    Myocarditis, pericarditis, mitral valve regurgitation, and depressed

    myocardial functioning can be recorded by electrocardiogram

    Sub-acute Stage (Days 11 to 30)

    Persistent irritability, anorexia, and conjunctival injection

    Thrombocytosis

    Decreased temperature

    Arthritis or arthralgia

    Desquamation of fingers and toes beginning at the periungual region

    Development of coronary aneurysms

    NOTE: This is the stage with the highest mortality

    Convalescent Stage (Day 30 and above)

    Inflammatory markers return to normal

    Disappearance of signs and symptoms

    Expansion of aneurysm leading to possible myocardial infarction

    Smaller aneurysms resolve independently (60% of cases)

    IV. Diagnostic Examinations and Medical Treatment

    The laboratory findings in KD are non-specific, but indicative of illness:

    Leukocytosis with neutrophilia (WBC in excess 15,000/mm3) with

    predominance of immature or mature granulocytse

    Elevated sedimentation rate (greater than 40mm/hour)

    Anemia (Hgb is below 110g/L)

    Thrombocytosis (Platelet count of more than 500,000/mm3)

    Hypoalbuminemia and hyponatremia

    Plasma lipid abnormalities

    Sterile pyuria

    Elevated serum transaminases

    5

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    6/49

    The medical treatment for Kawasaki Disease is intravenous

    immunoglobulin (IVIG) with supportive medication of aspirin for anti-platelet

    therapy:

    DRUG DOSAGE FREQUENCY

    IVIG 2g/kg infusion over 10 to 12

    hours OR;

    400mg/kg/day

    * IVIG may be repeated if fever

    persists or recurs together with at

    least one classic sign of KD

    Single dose

    For 4 days

    Aspirin 80-100mg/kg/day then;

    3-5mg/kg/day

    In 4 divided

    doses until

    14h day of

    illness and

    patient is

    afebrile for at

    least 3-4 days

    Once daily for

    6 to 8 weeks

    IVIG is a purified preparation of gamma globulin. It is derived from large

    collections of human plasma composed of several classes of antibodies. The

    effect that IVIG has in the treatment of KD is not exactly known, but prognosis is

    greatly improved after its administration no later than the tenth (10 th) day of

    illness. IVIG aids in the treatment of systemic inflammation, which causes the

    vasculitis in KD.

    High-dose aspirin is used for the treatment of inflammation in KD. Low-

    dose aspirin is used to inhibit platelet aggregation.

    6

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    7/49

    PATIENT PROFILE

    I. Demographic Data

    Name: Patient CDC

    Age: 1.5 years old

    7

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    8/49

    Address: Blk15 Lot 10, Our Mahogany 1 Village, Pulo, Cabuyao,Laguna

    Birthday: July 10, 2008

    Birth Place: San Pablo City, Laguna

    Religion: Roman Catholic

    Sex: F

    Nationality: Filipino

    Mothers Name: Roselia Age: 33 y/o Occupation: Employee (Human Resources)

    Fathers Name: Dante Age: 38y/o Occupation: Employee (Quality Control)

    II. Admission Data and Notes

    Hospital: Philippine Childrens Medical Center

    Date and Time of Admission: January 26, 2010 at 8:05pm (Emergency Room)

    January 27, 2010 (Ward 1C)

    Admission Diagnosis: ATP t/c Kawasaki Disease

    Chief Complaint: Persistent fever

    Attending Physicians: Dr. H. Lim and Dr. O. Teormoso

    Patient Weight: 11.5 kg

    Vital Signs: Temperature 39.5C

    Cardiac Rate 120 bpm

    Respiration Rate 30 cpm

    Blood Pressure 90/60 mmHg

    Doctors Admission Notes:

    System: awake, irritable

    EENT: cry, cracked lips

    Neck: (-) clap

    Lungs: SLE (-) retractions

    Heart: (-) murmur

    Extremities: good pulses, (+) edema

    Skin: (+) erythematous maculopapular rash in extremities

    (+) papular lesions in upper extremities and abdomen

    III. History of Present Illness

    8

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    9/49

    Patient CDC was admitted to the Emergency Room of the Philippine

    Childrens Medical Center on January 26, 2010 at 8:05pm. He was later

    transferred to Ward 1C (Non-Communicable Diseases) of PCMC on January 27.

    The chief complaint of the patient was persistent fever as verbalized by the

    mother.

    Six (6) days prior to admission, patient had fever with minimal coughing.

    Patient did not have rashes, diarrhea, or vomiting episodes. Patient was treated

    with Paracetamol at 10ml per dose for fever. Patient still had good activity and

    appetite.

    Three (3) days prior to admission, patient still had fever associated with

    erythema of the lips and eyes and rashes which erupted initially on the arms then

    to the trunk. Mother was unable to document temperature due to unavailability of

    thermometer.

    Two (2) days prior to admission, patient still had fever and was seen at the

    Laguna Health Center. Patient was given Paracetamol at 10ml per dose and

    Chlorpheniramine three doses for allergy. The medications did not offer relief. In

    the evening, the patient was given Cephalexin 125mg/5ml three times which also

    offered no relief.

    One (1) day prior to admission, patient was seen by a private doctor, whovisited patients home, due to persistent fever and papular rashes on the

    extremities. CBC was done at ASJ Medical and Diagnostic Clinic and revealed

    low platelet count. Patient was advised to be admitted to a hospital.

    On the day of the admission, patient was seen by doctors in Jose Reyes

    Memorial Medical Center. Patient was advised to go to PCMC.

    IV. Past Medical History

    Patient had no prior hospital confinements since birth. Patient did not

    have any notable illnesses in the past.

    V. Nutritional History

    9

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    10/49

    Patient CDC was breastfed for the first 2 weeks after birth. A milk formula

    was given from 2 weeks after birth to present. Ratio of formula is 1:1 milk to

    water given 6 ounces every 2 hours.

    Patient started eating cereals, meat, fruits, fish, and vegetables on the

    sixth (6th) month. Twenty-four (24) hours prior to confinement, patient ate bread

    and milk for breakfast, and rice and soup for lunch and dinner.

    Patient is given Celine for vitamins.

    Patient has no known food allergies.

    VI. Growth and Development

    For gross motor development, patient was reported to be able to stand

    and walk alone by the time he was 1 year old.

    For adaptive development, patient is able to indicate needs through

    minimal verbal cues and crying.

    For personal/social development, patient is able to use a spoon. Parents

    indicate that patient is able to let them know if she has urinated or defecated.

    Patient was able to do these after turning 1 year old.

    According to the physicians notes, patients growth and development are

    at par with age with no delays in development.

    VII. Family Health History

    Fathers Side: (+) cardiovascular accident

    (+) hypertension

    Mothers Side: (+) hyperthyroidism

    10

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    11/49

    PHYSICAL ASSESSMENT

    Name: Patient CDC

    Age: 1 years old

    Sex: Female

    Department: Ward 1-C

    Diagnosis: Kawasaki Disease.

    Date and Time of Assessment: January 29, 2010 4:00 PM

    I. General Survey

    Received patient lying on bed, awake and responsive, not in any respiratory distress. With IVF of

    0.9% NaCl 1000cc at right arm KVO. The patient measures 81cm in height and weighs 11.5kg. Patient appears to

    be restless and irritable as evidenced by increased movement and uncontrollable crying. Patient does not appear

    to be in respiratory distress.

    II. Vital Signs

    Techniques: Inspection, Palpation, Auscultation

    Patient has temperature of 38.4C, axillary with cardiac rate of 121 beats per minute, regular respiratory rate

    of 32 breaths per minute, and blood pressure of 90/60 mmHg.

    11

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    12/49

    PART TECHNIQUE NORMAL FINDINGS ACTUAL FINDINGS INTERPRETATION

    Skin Inspectionand

    Palpation

    Color varies from light todeep brown

    No edema

    Moisture in skin folds andaxillae

    Skin temperature isuniform within normalrange

    Erythematous andmaculopapular rashesare present on the back,abdomen, chest, andextremities

    Hands and feet arereddish, edematous,

    shiny, and dry-looking

    Skin is moist especially onareas with folds; presenceof desquamation onfingers, toes, and labialarea

    Skin temperature isuniformly warm due toelevated bodytemperature

    Presence oferythematous andmaculopapular rashesis one criteria indiagnosis of KawasakiDisease

    Changes in theperipheral extremities

    such as edema anddesquamation arecriteria for diagnosingKawasaki Disease

    Changes in theperipheral extremitiessuch as edema anddesquamation arecriteria for diagnosingKawasaki Disease

    Temperature of 38.4Cupon assessment;persistent fever for atleast 5 days is theearliest sign ofKawasaki Disease

    Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.

    Head Inspectionand

    Palpation

    Configuration isnormocephalic

    No lesions or tenderness

    Head is normocephalic inshape

    Absence of lesions and nosigns of tenderness

    Normal

    Normal

    12

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    13/49

    Anterior and posteriorfontanels are flat andclosed

    Anterior and posteriorfontanels appear to be flatand closed

    Normal

    Hair Inspection Evenly distributed, thickhair, silky, resilient, noinfestation

    Hair is thick, smooth,moist, and with no signs ofparasitic infestation

    Normal

    Eyes:Sclera

    Cornea

    Pupils

    Eye Balls

    Inspection

    Inspection

    Inspection

    Inspection

    Appears white

    Transparent, shiny,smooth with cornealdetails visible

    Black/brown in color;constricts whenilluminated and whenlooking at near objects;dilates when looking at farobjects

    Symmetrically aligned

    Eyeballs are symmetricalin size

    Not protruding

    Sclera is slightly reddish

    Transparent, shiny,smooth; details apparent

    Black in color; brisklyconstricts when illuminatedand dilates when notilluminated

    Aligned

    Eyeballs are symmetricalin shape and size

    There is no protrusion

    Bilateral non-purulentconjunctival injection

    is one of the signs ofKawasaki Disease

    Normal

    Normal

    Normal

    Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.

    13

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    14/49

    Palpebraland BulbarConjuctiva

    Inspection Smooth, pink or red Bulbar conjunctiva areslightly reddish in color

    Bilateral conjunctivalinjection is one of thecriteria in diagnosingKawasaki Disease

    Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. and

    Cherry, James D.Ears Inspecton

    andPalpation

    Auricles fair in color

    Symmetrical and alignedwith outer canthus of eyes

    Auricles are flexible, firm,no tenderness

    Absence of purulentdischarge in the externalcanal

    Patient responds to sound

    Auricles are fair in color,symmetrical in shape,flexible with no tenderness

    There is no discharge fromthe ear canal

    Responds to the voice ofmother and father

    Normal

    Normal

    Normal

    Nose Inspectionand

    Palpation

    Nares are patent

    Septum on the midline

    Mucosa is pinkish in color

    Patent nares with septumon the midline

    Mucosa is pinkish

    Normal

    Normal

    Mouth Inspectionand

    Palpation

    Lips are moist and pinkishin color

    Oral mucosa is pinkishwith no ulcerations

    Lips are red in color, dry,and cracked

    Oral mucosa is also deepred in color

    Tongue is red and hasstrawberry-like texture

    No ulcerations in oralmucosa

    Changes in the mouthand oral mucosa are

    some of the signs ofKawasaki Disease

    Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.

    Neck Inspectionand

    Neck is symmetrical

    Thyroid glands are not

    Neck is symmetrical

    Presence of a swollen

    Normal

    Unilateral cervical

    14

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    15/49

    Palpation tender and enlarged

    Neck muscles are equalin size

    Trachea is positionedmidline upon palpation

    lymph node on the leftside of the neck ; size ofthe lymph node isapproximately 1.5cm

    Neck muscles are equal insize

    Trachea is positionedmidline

    lymphodenopathyappears in 50% to 75%of patients withKawasaki Disease

    Normal

    Normal

    Source: Textbook of

    Pediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.

    Chest Inspection,Palpation,Auscultation

    Full and symmetric andnot bulging

    Breathing is abdominaland posterior mobility andposture of thorax issymmetrical uponrespiration

    Clear breath sounds

    Chest is not bulging andappears symmetrical

    Abdominal breathing ispresent (pediatric) withthoracic movementsymmetrical

    No presence of harsh

    breath sounds; patient wascrying and irritable duringassessment

    Normal

    Normal

    Normal

    Heart Auscultation S1 usually heard at allsites but louder at apicalarea

    S2 usually heard at allsites but louder at base ofthe heart

    S1 and S2 are heardaudibly on apical and baseareas of the heart

    No murmur or gallops (S3and S4)

    Normal

    Breast Inspection Symmetrical in size andshape

    Symmetrical in size andshape

    Normal

    15

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    16/49

    Areola is round or ovaland color is light pink todark brown

    Nipples are round, andequal in size

    Areola is small and brownin color

    Nipples are round andalmost in size

    Normal

    Normal

    Finger andToe Nails

    Inspectionand

    Palpation

    Vascular and pinkish incolor

    Smooth texture

    Intact epidermis

    Capillary refill in 3-5seconds

    Fingers and toes aredesquamated,

    edematous, and reddishin color

    Smooth texture

    Intact epidermis

    Capillary refill of 3 seconds

    Changes inextremities such as

    edema, desquamation,and redness are signsof Kawasaki Disease

    Normal

    Normal

    Normal

    Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.

    Abdomen Inspection,Auscultation,

    Palpation

    Unblemished skin,uniform in color

    no evidence of liverenlargement

    Audible bowel sounds

    Presence oferythematous andpolymorphous rashes on

    the trunk

    no evidence of liverenlargement

    Audible bowel sounds at12 per minute; abdomenproduces a growling sound

    Presence ofpolymorphousexanthema or rashes

    is one sign ofKawasaki Disease

    Normal

    Normal

    Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.

    16

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    17/49

    Muscles Inspection,Palpation

    Equal size on both sidesof the body; nocontractures

    Good muscle tone, firmwith smooth coordinatedmovements

    Symmetrical in size onboth sides of the body

    Good muscle tone with nosigns of uncoordinatedmotor movement

    Normal

    Normal

    Source of Normal Figures: Fundamentals of Nursing: Concepts, Process, and Practice Seventh Edition by Kozier, Barbara and

    Erb, Glenora

    Maternal & Child Health Nursing: Care of the Childbearing & Childrearing Family Fifth Edition byPillitteri, Adele

    17

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    18/49

    ANATOMY

    Kawasaki Disease, otherwise known as Mucocutaneous Lymph Node Syndrome,

    is an acute, self-limiting, and febrile systemic vasculitis that may cause cardiac

    complications. The most common sequel of KD is coronary thrombosis (stagnant blood

    clot) that possibly leads to the development of a coronary aneurysm. Having these

    definitions and descriptions of the disease in mind, the following body systems and

    structures will be discussed briefly to illustrate the physiological effects of KD.

    I. Heart

    The heart functions as the primary organ for blood circulation in the

    human body. It is responsible for delivering un-oxygenated blood from the

    venous system to the lungs and oxygenated blood from the lungs to the arterial

    circulation. Additionally, the heart propels blood throughout the systemic

    (arterial) circulation to bring nutrients, vital enzymes, hormones, and drugs to the

    tissues and organs of the body. The image of the heart, its parts and functions,

    are illustrated in Figure 1 and Table 1 respectively.

    FIGURE 1: THE HEART AND ITS STRUCTURES

    18

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    19/49

    TABLE 1: THE PARTS OF THE HEART AND CORRESPONDING FUNCTION

    STRUCTURAL PARTS FUNCTION

    Superior Vena Cava (SVC) One of the two main veins that drains un-

    oxygenated blood to the right atrium

    Blood from the head and upper body

    drain into the SVC

    Inferior Vena Cava (IVC) The second main vein that drains un-

    oxygenated blood to the right atrium

    Blood from the legs and lower torso drain

    into the IVC

    Aorta The largest single blood vessel in the

    body

    Passageway for oxygen-rich blood from

    the left ventricle into the systemic

    circulation

    Pulmonary Artery The only artery in the body that carries

    deoxygenated blood

    Passageway of deoxygenated blood from

    the right ventricle to the lungs

    Pulmonary Vein The only vein in the body that carries

    oxygenated blood

    Carries oxygenated blood from the lungs

    to the left atrium

    Right Atrium A chamber of the heart that receives

    deoxygenated blood from the SVC and

    IVC

    Pumps blood into the right ventricle via

    the tricuspid valveRight Ventricle Receives deoxygenated blood from the

    right atrium via the tricuspid valve

    The tricuspid valve closes after the right

    ventricle fills up with blood and the

    19

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    20/49

    pulmonary valve opens to allow

    deoxygenated blood to flow into the

    pulmonary artery

    Left Atrium Receives oxygenated blood from the

    pulmonary vein

    Blood from this chamber empties into the

    left ventricle via the mitral valve

    Left Ventricle Arguably the largest chamber of the

    heart, receives oxygenated blood from

    the left atrium via the mitral valve

    The mitral valve is open as the left

    ventricle fills up with blood from the leftatrium and it closes once the left ventricle

    is filled. The aortic valve opens as the

    left ventricle contracts, sending

    oxygenated blood into the aorta and into

    the systemic circulation

    Atrioventricular Valves The tricuspid and mitral valves ensure

    one-way blood flow within the chambers

    of the heart

    The tricuspid valve is the gateway

    between the right atrium and the right

    ventricle

    The mitral valve is the gateway between

    the left atrium and the left ventricle

    Semilunar Valves The pulmonary and aortic valves ensure

    one-way blood flow into the pulmonary

    artery and aorta respectively

    20

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    21/49

    II. Coronary Arteries

    The coronary arteries constitute the coronary circulation that supplies

    oxygenated blood to the heart itself. These arteries receive their blood supply

    from openings in the aorta called the coronary ostia.

    A major complication of Kawasaki Disease is the development of coronary

    aneurysms and coronary thrombosis, thus making the discussion of the coronary

    arteries relevant. Ruptured coronary aneurysms lead to massive bleeding and

    ischemia, eventually resulting to myocardial infarction.

    The main branches of the coronary arteries and the areas of the heart

    they supply are detailed below (Figure 2 and Table 2).

    Figure 2: The Coronary Circulation

    21

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    22/49

    Table 2: The Branches of the Coronary Arteries

    BRANCHES OF THE

    CORONARY ARTERIES

    PARTS SUPPLIED

    Left Coronary Artery Divides into two branches: the left anterior

    descending artery and the circumflex artery

    Left Anterior Descending Artery Delivers blood to sections of the left and

    right ventricles and majority of the

    interventricular septum

    Circumflex Artery Supplies blood to left atrium and the lateral

    wall of the left ventricle

    Right Coronary Artery Three major branches: conus, right marginal

    branch, and posterior descending branch

    The conus supplies blood to the right upper

    ventricle, the right marginal branch supplies

    the right ventricle up to the apex, and the

    posterior descending branch supplies

    minority sections of the ventricles

    22

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    23/49

    III. Vascular System

    The vascular system is made up of the arteries and veins of the body.

    Arteries branch into smaller arterioles, which branch further into capillaries.

    Capillaries serve as the site where nutrient exchange between the blood and

    tissues occur. Blood from the capillaries then enter venules that eventually join

    together to form larger veins. The arteries serve as the channels for oxygenated

    blood (systemic circulation) and the veins serve as the channels for

    deoxygenated blood.

    As a systemic vasculitic disease, Kawasaki Disease causes inflammation

    of the blood vessels resulting to edema, increased permeability of the vessels,

    and coronary aneurysms (weakening of the blood vessel walls). Figure 3 and

    Table 3 briefly discuss the structure and functions of the vascular components.

    Figure 3: The Vascular System

    23

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    24/49

    Table 3: Comparison of Arteries and Veins

    ARTERIES PARTS VEINS

    Thinner than the tunica

    media

    Tunica Adventitia (outer

    layer)

    Thickest layer

    Thicker than the tunicaadventitia allowing

    vasoconstriction and

    vasodilation

    Tunica Media (middlelayer)

    Thinner in veins

    Same Tunica Intima (inner layer) Same

    Narrower Lumen Wider to accommodate

    valves

    Absent Presence of Valves Present; to ensure the one-

    way flow of blood back to

    the heart

    Fastest in arteries and gets

    slower when entering the

    arterioles and capillaries

    Blood Flow Slow in the venules, but

    increases speed as it

    passes through the veins

    (valve-related)

    Aorta (largest), pulmonary

    artery, carotid arteries,

    subclavian artery,

    brachiocephalic, abdominal

    aorta, common iliac, brachial

    Major Blood Vessels Superior and inferior vena

    cavae, jugular veins,

    subclavian veins, hepatic,

    iliac, femoral, hepatic portal

    24

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    25/49

    Figure 4: Arteries of the Body

    Figure 5: Veins of the Body

    25

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    26/49

    IV. Lymph Nodes

    The lymph nodes are some of the major structures of the lymphatic

    system, which works closely with the circulatory system to bring interstitial fluid

    back into the blood circulation. Functionally, however, lymph nodes are part of

    the hematologic and immune systems because large numbers of lymphocytes,

    monocytes, and macrophages reside in these nodes. These cells are mobilized

    and join the circulating blood during infection or inflammation.

    In Kawasaki Disease, there is unilateral lymphodenopathy, meaning that

    the lymph nodes enlarge due to inflammation. What causes this inflammation is

    still unknown, but since unilateral lymphodenopathy is one criterion in diagnosing

    KD, it is worth to include it in the anatomy section of this study.

    Figure 6: Parts of a Lymph Node

    26

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    27/49

    27

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    28/49

    PATHOPHYSIOLOGY

    Sources:

    1. Textbook of Pediatric Infectious Diseases Fifth Edition by Feigin, Ralph D. andCherry, James D.

    2. Kawasaki Disease by Scheinfeld, Noah S. and Jones, Elena L.

    http://emedicine.medscape.com/article/965367-overview

    28

    Diagnostic indicators

    Complications if untreatedwithout IVIG 10 days after onset

    of fever

    Signs and symptoms inpatient

    Diagnosis of KawasakiDisease based on

    diagnostic criteria ofdisease;

    Age is the only probablepredisposing factor in

    patient

    (+) fever

    (+) maculopapularerythematous rashes onhands, feet, trunk, and

    abdomen;(+) edema of hands and

    feet;(+) desquamation of

    fingers, toes, andperiungual area

    (+) palpable unilateral

    cervicallymphadenopathy at

    1.5cm

    (+) bilateral nonpurulentconjunctivitis

    (+) cracked lips;(+) strawberry tongue;

    Remittent fever for 6days PTA;

    T = 39.5C on DOA

    Platelet level of 411 x103 g/L based on CBC;

    ESR of 112 mm/hrbased on CBC

    WBC count of 19.7 g/L

    based on CBC;Segmenter count of 0.85

    hpf based on CBC

    Coronary aneurysm;Coronary thrombosis;

    Coronary stenosis;Coronary arteritis

    Myocardial infarction;Congestive heart

    failure;Death

    http://emedicine.medscape.com/article/965367-overviewhttp://emedicine.medscape.com/article/965367-overview
  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    29/49

    Discussion:

    The etiology of Kawasaki Disease is still unknown. Studies have failed to identify

    a pathologic agent that causes the disease. Most clinicians believe the disease has an

    infectious nature due to the presence of seasonal outbreaks in Japan. The only non-

    modifiable risk factors with considerable theoretical basis are age and race. Most casesinvolve children below 10 years of age and Japanese children appear to be at a higher

    risk of acquiring the disease. However, the incidence of KD in Asians and other Pacific

    Islanders is higher compared to Westerners of Caucasian or African descent.

    The patient manifested 5 out of the 6 signs in the criteria for diagnosing

    Kawasaki Disease. The patient had remittent fever for 6 days, had rashes that started

    in the arms and spread to the trunk, oral cavity changes manifested by cracked lips,

    strawberry tongue, and reddened oral mucosa, bilateral conjunctivitis, and a palpable

    lymph node on the lefts side of the neck. These clinical manifestations were supported

    by the hematological test and vital signs of the patient: a temperature of 39.5C,elevated platelet (thrombocytosis) and ESR (inflammatory response) levels, and a left

    shift (increased production of mature leukocytes) in the patients WBC differential

    results. The hematological results further provide evidence of the multi-system

    affectations of the disease indicating signs of inflammation (vasculitis in KD), formation

    of blood clots, and abnormal increase in WBCs (manifested in lymphadenopathy.

    Twenty-five percent (25%) of cases result to coronary artery complications

    without IVIG therapy and 3% of cases lead to the same complications even with IVIG

    therapy. The coronary artery complications include formation of blood clots, arterial

    stenosis, arteritis, and aneurysms. If these complications are not detected, the worst-case prognoses are myocardial infarction, congestive heart failure, and death. KD has a

    0.1 to 2% mortality rate globally.

    29

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    30/49

    DIAGNOSTIC EXAMINATIONS

    Hematology Section - PCMC

    Name: Patient CDC

    Date received: January 26, 2010 - 9:34 pm

    Date released: January 26, 2010 - 10:34 pm

    PARAMETERS RESULTS NORMAL

    VALUES

    FINDINGS ANALYSIS

    Hemoglobin

    (HGB)

    107.6 116-140g/L Below normal Indicative of

    anemia, which

    is a diagnostic

    predictor ofKawasaki

    Disease

    Hematocrit

    (HCT)

    0.34 0.35-0.41g/L Slightly below

    normal

    Lysis of RBC

    is possibly

    due to

    vasculitic

    affects of

    disease

    RBC 4.36 3.6-50g/L Normal There is noabnormal

    finding

    WBC 19.7 5-10g/L Remarkably

    above normal

    Indicative of

    leukocytosis

    secondary to

    infection or

    inflammation

    Differential Count

    30

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    31/49

    PARAMETERS RESULTS NORMAL

    VALUES

    FINDINGS ANALYSIS

    Eosinophils 0.01 0.02-0.07hpf Slightly below

    normal

    Possibly due to

    allergic

    reactions

    Segmenter 0.85 0.55-0.65 hpf Remarkably

    above normal

    Overproduction

    of mature

    leukocytes

    indicative of

    increased

    autoimmune

    response

    Lymphocytes 0.14 0.25-0.35 hpf Remarkably

    below normal

    Indicative of

    immunosupp-

    ression

    Platelet Count 411 150-350 x

    103 /L hpf

    Remarkably

    above normal

    Indicative of

    thrombocytosis,

    which appears

    on the 2nd week

    of Kawasaki

    Disease

    ESR 112 0 -20 mm/hr Remarkably

    above normal

    Indicative of

    inflammatory

    response

    ASJ Medical and Diagnostic Clinic

    Hematology

    31

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    32/49

    Date of Release: January 25, 2010

    PARAMETERS RESULTS NORMAL

    VALUES

    FINDINGS ANALYSIS

    Hemoglobin

    (HGB)

    106 116-140g/L Below normal Indicative of

    anemia

    Hematocrit

    (HCT)

    0.32 0.35-0.41g/L Slightly below

    normal

    Indicative of

    low RBC

    count due to

    hematologic

    factors

    ErythrocyteCount

    3.7 3.6-50g/L Normal Within normal

    range

    LeukocyteCount

    5.75 5-10g/L Normal Within normal

    range

    Platelet Count 98,000 150,000

    300,000

    Below normal Indicative of

    thrombocyto-

    penia

    Differential Count

    PARAMETERS RESULTS NORMAL

    VALUES

    FINDINGS ANALYSIS

    Eosinophils 0.03 0.02-0.07hpf Normal Within normal

    range

    Segmenter 0.55 0.55-0.65 hpf Normal Within normal

    range

    Lymphocytes 0.40 0.25-0.35 hpf Slightly above

    normal

    Indicative of

    autoimmune

    response

    Monocytes 0.02 0.02-0.05 Normal Within normal

    32

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    33/49

    range

    33

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    34/49

    DRUG STUDY

    DRUG DOSAGE MECHANISM OF

    ACTION

    INDICATION CONTRAINDICATION ADVERSE

    EFFECT

    NURSING

    RESPONSIBILITIES

    Drug Name:

    IMMUNOGLOB-ULIN IV

    Drug Class:

    Passive immune-globulin

    2.5g/50ml 10 vials:

    Test Dose I:0.01x11.5kgx60= 7cc for 30mins

    Test Dose II:0.02x11.5kgx60=14cc

    Test Dose III:0.03x11.5kgx60=21cc

    Test Dose IV:0.04x11.5kgx60=28cc

    Translateremaining 390cc to24cc/hr for 16hrs

    Improves immunityby binding to and

    neutralizing

    pathogens, thereby

    increasing

    antibodies against

    bacterial, viral,

    parasitic, and

    mycoplasmic

    antigens. Acts

    through

    antimicrobial and

    antitoxin

    neutralization.

    KawasakiSyndrome

    Prophylaxis after

    exposure to

    Hepatitis A

    B-cell chronic

    lymphocytic

    leukemia

    Pediatric HIV

    infection

    Patients withanaphylactic reaction to

    IGIV

    Tenderness,muscle stiffness at

    injection site,

    nausea, vomiting,

    chills, fever,

    headache.

    - Do not administer topatients with history of

    allergy to gammaglobuli

    - Instruct patient to repor

    symptoms occurring

    during or after therapy.

    - Use with caution in

    pregnant women-

    Pregnancy C; safety not

    established

    - Have epinephrine 1:10

    immediately available at

    time of injection in case

    anaphylactic reaction

    - Do not mix immune

    globulin with any other

    medications

    - Monitor patients VS

    continuously

    - Provide or teach patien

    to provide safety

    measures.

    34

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    35/49

    - Advise patient to avoid

    live-virus vaccines for 3

    months after therapy; dr

    may delay or inhibit body

    response to vaccine.

    - Provide patient with

    written record of injection

    and dates for follow-up

    injections as needed.

    DRUG DOSAGE MECHANISM OF

    ACTION

    INDICATION CONTRAINDICATION ADVERSE

    EFFECT

    NURSING

    RESPONSIBILITIES

    Drug Name:

    ASPIRIN

    Classification:

    Antipyretic,analgesic, NSAID

    300mg/tab; 1 tab

    q6 PO

    It acts in the

    thermoregulatory

    center of the

    hypothalamus to

    block effects of

    pyrogen

    Also has anti-

    inflammatory, anti-

    platelet, and

    analgesic

    properties

    Mild to moderate

    pain

    Fever

    Inflammatoryconditions-

    rheumatic fever,

    rheumatoid

    arthritis,

    osteoarthritis

    Allergy to NSAID or

    salicylates

    Hemophilia;

    hemorrhagic states;

    impaired renal function;chickenpox; pregnancy

    Acute aspirin

    toxicity: tachypnea,

    hemorrhage,

    excitement,

    confusion

    GI: nausea,

    dyspepsia,

    heartburn,

    epigastric

    discomfort,

    anorexia

    - Give drug with food or

    after meals if GI upset

    occurs.

    - Use the drug only as

    suggested; avoidoverdose.

    35

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    36/49

    NURSING CARE PLAN

    The following nursing problems were based on the data gathered for this study:

    I. Actual Nursing Problems

    1. Elevated body temperature related to systemic inflammation of blood

    vessels secondary to present disease

    2. Impaired skin integrity related to accumulation of fluid in the interstitial

    spaces of hands and feet secondary to present disease

    3. Impaired oral mucous membrane related to inflammation of oral mucosa

    secondary to present disease

    II. Potential Nursing Problems

    1. Risk for decreased cardiac output related to possible coronary artery

    complications secondary to present disease

    36

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    37/49

    ACTUAL NURSING PROBLEMS

    1. Elevated body temperature related to systemic inflammation of blood vessels secondary to present disease

    ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective:NONE

    Objective:

    Temp 38.4C;

    Warm to touch;

    Irritable andrestless;

    Uncontrolledcrying

    Elevated bodytemperaturerelated tosystemic

    inflammationof bloodvesselssecondary topresentdisease

    Presentdisease

    Systemicinflammationof bloodvessels

    Release ofpyrogens

    Elevated bodytemperature

    Short-term:

    After 2 hoursof nursing

    intervention,the patientstemperaturewill normalizeat 37.5C.

    Independent:

    Checktemperature and

    other vital signsprior tointerventions;

    Administer tepidsponge bath tolowertemperature;

    Provide a changeof clothes andsheets to promote

    increasedcomfort;

    Regularly checkdiapers if soiled;

    Assessmentof all vital

    signs isintegral toplanning andintervention;

    TSB is anindependentnursingfunction thatlowers coretemperature;

    Increasingpatientcomfort can

    ease irritabilityandrestlessnessassociatedwith fever;

    Soiled diaperscauseadditionaldiscomfort;

    After 2 hours ofnursingintervention, thepatients body

    temperaturewas lowered to37.8C; tocontinueinterventionsuntil bodytemperaturenormalizes

    37

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    38/49

    Follow feedingschedule toprovide nutritionalsupport;

    Watch out forsigns ofdehydration

    Dependent:Administer aspirinas ordered;

    Check the flowrate of IVIG andwatch out forsigns of adverseeffects

    Infants requiresufficientnutritionespeciallyduring timesof illness andimmuno-suppression;

    Dehydration iscommon ininfants withpersistentfever

    Aspirin servesas anantipyretic,anti-inflammatoryand anti-platelet drug

    in KawasakiDiseaseProperregulation ofIVIG infusionis important toprevent sideeffects

    2. Impaired skin integrity related to accumulation of fluid in the interstitial spaces of hands and feet secondary to

    present disease

    38

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    39/49

    ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective:NONE

    Objective:

    + 1 edema ofhands and feet;

    Skin appears dryand shiny;

    With erythema ofhands and feet;

    desquamation offingers and toes

    Impaired skinintegrityrelated toaccumulationof fluids ininterstitialspaces of

    hands andfeetsecondary topresentdisease

    Presentdisease

    Systemicinflammation

    of blood

    vessels

    Increase inhistaminerelease

    Greaterpermeability

    of bloodvessels

    Vascular fluid

    moving tointerstitialspaces ofhands and

    feet

    Impaired skin

    Short-term:After 6 hoursof nursingintervention,skin integrityimproved asevidenced by

    controlleddryness of theskin

    Long-term:

    After 3 to 4days ofnursingintervention,skin integrityproblemsrelated toedema willresolve as

    evidenced byedema scoreof 0 from +1

    Independent:

    Assess the handsand feet for extentof dryness andedema;

    Assess mobility offingers, toes,hands, feet,wrists, andankles;

    Apply RICEtechnique inmanagement ofedema;

    Apply lotion to dry

    Assessmentof sites ofedema willdictateprovision

    interventions;

    Mobility is asign ofsufficientblood flow tosites;

    R- rest;I ice todecreaseinflammation;C compressionto promote

    venous returnand lymphaticdrainage offluid;E elevateabove theheart forvenous return;

    Lotion can

    After 6 hours ofnursingintervention,skin integrityimproved withcontrolleddryness of the

    skin ; skin ismore moist onsites of edema

    39

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    40/49

    integrity areas of skin for moisture andlubrication;

    Do not peel offdesquamatedskin;

    Watch out forwounds and signsof infection andloss of function

    Dependent:Administer aspirinas prescribed;

    Check flow ofIVIG asprescribed

    hasten furtherdrying of theskin due toedema;

    Desquamatedskin will peeloff naturally;you can cutloose skin atthe ends;

    Edema anddryness makeskinsusceptible towounds

    Aspirin hasanti-inflammatoryproperties;

    IVIG therapyaids in abatinginflammation,thus reducingedema

    3. Impaired oral mucous membrane related to inflamed oral mucosa secondary to present disease

    ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective: Impaired oral Present Short-term: Independent: After 3 hours of

    40

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    41/49

    NONE

    Objective:

    With fissured,cracked lips;

    Witherythematouslips;

    red and inflamedoral mucosa;

    Strawberry-liketongue withpapules;

    Irritable whenbeing givenfeedings

    mucousmembranerelated toinflamed oralmucosasecondary topresentdisease

    disease

    Inflamed oralmucosa

    Poor bloodperfusion tooral mucousmembrane

    Impaired oralmucous

    membrane(evidenced bycracked lips)

    After 3 hoursof nursingintervention,fissures andcracks in thelips will becontrolled andlessened

    Long-term:

    After 3 to 4days ofnursingintervention,fissures andcracks willresolve asevidenced bymoist lips withthe absenceof cracks and

    fissures

    Assess the extent,characteristic, andseverity of thefissures andcracks on the lips;

    Assess if there isdifficulty inswallowing oralterations infeeding;

    Provide oralrinses using tapwater or salinedrops to moistenmucosa;

    Provide regularoral care hygieneby giving oralrinses;Encouragesufficient fluid

    Assessmentof the fissuresand cracks onthe lips willaffectinterventionsto be given;

    Fissured andcracked lipscan causedifficulty infeeding,especially ininfants;

    Moisteningdried mucosawill preventworsening ofcracks andprevent new

    ones fromdeveloping

    Non-alcoholicrinses willpreventinfectionDehydrationcan contribute

    nursinginterventions,fissured andcracked lipswere managedas evidenced bycontrolleddryness of thelips

    41

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    42/49

    intake asprescribed andtolerated;

    Instruct mother toavoid giving acidicfluids;

    Instruct mother tocontinue feedingpractices asprescribed byphysician

    Watch out forsigns of infection

    Independent:

    Administer aspirinas prescribed

    to mucosaldryness andworsencracked lips;

    Juices andother acidicbeveragescause pain inopen oralmucosa;

    Feedingpracticesshould beencouraged inspite ofcondition

    Further dryingof mucosa canlead to ulcersand result to

    infection

    Aspirin hasanalgesic andanti-inflammatoryproperties

    42

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    43/49

    Potential Nursing Problems

    1. Risk for decreased cardiac output related to possible coronary artery complications secondary to present disease

    ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective:None

    Objective:

    Risk fordecreasedcardiac outputrelated to

    Presentdisease

    Short-term:

    After 2 hoursof nursing

    Independent:

    Assess thepatients cardiac

    It is importantto retrieve

    After 2 hours ofnursingintervention, theparents were

    43

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    44/49

    None possiblecoronaryarterycomplicationssecondary topresentdisease

    Increasedplatelet

    production

    Formation ofblood clots inblood vessels,

    particularlythe coronary

    arteries

    Blood clotscan causeblockage,

    aneurysms,and stenosisof coronary

    arteries

    All these

    complicationscan causedecreased

    cardiac output

    intervention,the parentswill be able toverbalizeunderstandingof the cardiaccomplicationsof presentdisease

    vital signs prior todischarge;

    Discuss withparents the natureof KawasakiDisease and thepossiblecomplicationseven with IVIGtherapy;

    Provide parentswith aninformation sheetregarding post-drug therapy carefor patients withKawasakiDisease;

    Instruct parents topromote adequaterest and sleep 2-3days afterdischarge fromhospital;

    Instruct parents togradually

    baseline VSprior todischarge forreference;

    Clienteducation isimportant incomprehen-sion of illness

    A quickreferenceguide canincreaseunderstan-ding ofdisease;

    Patients fullrecovery hasto be ensured;

    Gradualreintroduction

    able tounderstand therisk for cardiaccomplicationsas evidenced byverbalization oftheircomprehensionof healthteachings

    44

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    45/49

    reintroducepatient toactivities;

    Educate patientson signs ofcardiac problems;

    Promote abalanced diet withlow sodiumcontent;

    Advise parentsregarding followup check-up anddiagnosticprocedures

    to activitieswill helppatient adaptefficiently afterillness;

    Signs ofcardiaccomplicationsinvolveshortness ofbreath, activityintolerance,difficulty inbreathing,dizziness,lethargy, andchest pain;

    Propernutrition willensure growthand

    development;

    Follow upcheck-ups willhelpdeterminedevelopmentof any cardiacabnormalitiesor coronary

    45

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    46/49

    arteryaffectations

    46

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    47/49

    DISCHARGE PLANNING

    Medication

    Discuss all take home medications to patient's mother

    Aspirin: advise parents to give drug after meals to prevent gastric irritation

    Aspirin: advise parents regarding side effects of drug such as nausea,vomiting, abdominal pain, and headache

    Aspirin: advise parents to adhere to frequency, dosage, and timeliness ofdrug administration

    IVIG: educate parents regarding immunosuppressive effects of drug

    IVIG: educate parents regarding side effects of drug such as chills, fever,

    and headache

    Advise parents to report any changes in the patient related to drugs beingtaken

    Exercise

    Advise parents of adequate rest and sleep for up to 2 to 3 days after discharge topromote recovery

    Advise parents to gradually increase activities; start with light activities until

    tolerated before engaging in more strenuous activities

    Encourage parents to have patient engage in normal activities of daily living suchas self-feeding, dressing, and walking

    Constantly monitor activity and exercise pattern to detect any abnormalities suchas cardiac affectations/sequelae of Kawasaki Disease

    Treatment

    Explain to the patients that drug therapy should continue as prescribed byphysician

    Educate parents regarding potential sequelae of Kawasaki Disease such ascoronary artery and cardiac problems

    Health Teachings

    Advise parents to promote proper hygiene to decrease possibility of infection

    47

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    48/49

    Encourage parents to promote a safe, comfortable, and clean environmentconducive to recovery of patient

    Provide nutritional teaching to parents to foster improved nutritional and fluidintake as well as promote balanced diet

    During recovery, patient should not be brought to crowded places to preventcommunity-acquired infections

    Advise mother to complete all immunizations and booster shots for patient oncecleared by physician

    Promote regular hand washing especially during food preparation to avoidcontamination of food

    Out Patient

    Remind the family on their follow up check up with their physician

    Encourage to take routine cardiac diagnostic examinations (i.e. MRI, CTscans of

    the heart, and 2D echocardiography) to determine presence of cardiac

    affectations/complications of disease

    Diet

    Encourage to have the three basic food groups in the diet while controlling salt

    intake

    Encourage to increase fluid intake

    Encourage to prepare foods that are rich in vitamins and minerals to improve

    immune system

    Continue milk feeding and solid food combination and introduce new viands to

    improve appetite and expand food variety

    Spiritual

    Guided by the family, help the patient to establish deep personal relationship withGod in everyday of her waking moment

    With guidance from parents and family, help the patient find happiness in her

    present situation

    Aid patient in holistic development of self to promote overall wellness

    48

  • 8/7/2019 GRAND CASE STUDY V7 FINAL 030310

    49/49

    REFERENCES

    Books

    Feigin, Ralph D. et al., Textbook of Pediatric Infectious Diseases Volume 1. Fifth

    Edition. Elsevier Inc., Philadelphia, USA: 2004.

    Huether, Sue E. and McCance, Kathryn L.,Understanding Pathophysiology 3 rd Edition.

    Mosby Inc., Singapore: 2004.

    Kozier, Barbara et al., Fundamentals of Nursing: Concepts, Process, and Practice

    Seventh Edition. Prentice Hall, New Jersey, USA: 2004.

    Pillitteri, Adele, Maternal & Child Health Nursing: Care of the Childbrearing &

    Childrearing Family Volume 2 Fifth Edition. Lippincott Williams & Wilkins, USA:

    2007.

    Internet

    Gordon, John B. et al. When Children with Kawasaki Disease Grow Up: Myocardial and

    Vascular Complications in Adulthood., Journal of the American College of

    Cardiology as seen on http://www.medscape.com/viewarticle/712188

    Moran, Adrian M. et al. Abnormal Myocardial Mechanics in Kawasaki Disease: Rapid

    Response to Gamma-Globulin., American Heart Journal 02/01/2000 as seen on

    http://www.medscape.com/viewarticle/409087

    Scheinfeld, Noah S. and Jones, Elena L. Kawasaki Disease., 10/20/2009 as seen on

    http://emedicine.medscape.com/article/965367-overview